NPSGY yields 60.06% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 10
Combined, NPSGY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NPSGY + MRK for your $10,000?
Nippon Sheet Glass Company, Limited manufactures and sells glass and glazing products worldwide. It operates through Architectural, Automotive, Technical Glass, and Other segments. The company offers architectural products, including solar control, thermal insulation, fire protection, noise control, safety/security, self-cleaning, decoration, solar energy, and antimicrobial glasses; glass systems; and coated or non-coated glasses the Pilkington brand. It also provides automotive products, such as automotive glass products for vehicle original equipment manufacturers; aftermarket glass replacement products; and glass solutions for specialized vehicles, which include commercial, off-road, bus and coach, marine, and rail. In addition, the company offers functional products under the MICROGLAS, Flake, Metashine, GLASFLAKE, and SILKYFLAKE names; absorbent glass mat (AGM) separator, a component for valve regulated lead-acid batteries; polyethylene (PE) separator, which allows the battery assembly line to run efficiently; and sleeve tubes, which are used as the separators for positive plate of clad type lead-acid batteries. Further, it provides SELFOC lens arrays and micro lenses; SELGUIDE, a linear LED light source for image scanning; sheet glasses for electronic office devices; and ultra-fine flat glasses. The company was formerly known as America Japan Sheet Glass Co., Ltd. and changed its name to Nippon Sheet Glass Company, Limited in 1931. Nippon Sheet Glass Company, Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.
Full NPSGY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.